Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
Add more filters










Publication year range
2.
Pediatr Infect Dis J ; 35(3): 281-5, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26650114

ABSTRACT

BACKGROUND: The significance of Clostridium difficile (CD) in the stools of children 2 years old or younger remains unclear. The aim of this study was to investigate risk factors and clinical evolution of diarrheic children ≤2 years old with or without CD in their stools. METHODS: From January 1, 2012 to December 31, 2013, all diarrheic stool samples received in our laboratory were screened for CD. We randomly selected diarrheic children ≤2 years old (n = 100) with an isolation of toxigenic CD in the stools and compared them with diarrheic children (n = 100) without isolation of CD. RESULTS: Cases and controls were appropriately matched for age and sex. We found no significant differences between children with or without CD. Of the CD cases, we compared the patients receiving treatment with metronidazole (19%) versus those that were not prescribed treatment (81%), and found that patients in the first group had used more gastric acid suppressants (P = 0.02), had surgery in the last month (P = 0.03) and also presented with more days with diarrhea (P = 0.03). All the patients, including CD cases, independently of the administration of metronidazole, were cured of the diarrheic episode. Polymerase chain reaction-ribotyping performed in all CD cases showed that the most prevalent ribotype was 014 (25%). CONCLUSIONS: Our study reinforces the nonsignificance of CD in neonates and infants younger than 2 years old. Informing clinicians of CD isolates in this population promotes the use of antibiotics against CD, without evidence of a different outcome than those not receiving treatment.


Subject(s)
Clostridioides difficile/isolation & purification , Clostridium Infections/epidemiology , Clostridium Infections/microbiology , Diarrhea/epidemiology , Diarrhea/microbiology , Case-Control Studies , Community-Acquired Infections , Cross Infection , Feces/microbiology , Female , Humans , Infant , Infant, Newborn , Male , Risk Factors
3.
J Clin Microbiol ; 53(11): 3423-9, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26269618

ABSTRACT

The strains involved in tuberculosis outbreaks are considered highly virulent and transmissible. We analyzed the case of a patient in Madrid, Spain, who was persistently infected over an 8-year period by the same Beijing Mycobacterium tuberculosis strain. The strain was responsible for a severe outbreak on Gran Canaria Island. The case provides us with a unique opportunity to challenge our assumptions about M. tuberculosis Beijing strains. No clinical/radiological findings consistent with a virulent strain were documented, and the in vitro growth rate of the strain in macrophages was only moderate. No secondary cases stemming from this prolonged active case were detected in the host population. The strain did not acquire resistance mutations, despite constant treatment interruptions, and it remained extremely stable, as demonstrated by the lack of single-nucleotide-polymorphism (SNP)-based differences between the sequential isolates. Our data suggest that the general assumption about M. tuberculosis Beijing strains having advantageous properties (in terms of virulence, transmissibility, and the tendency to acquire mutations and resistance) is not always accurate.


Subject(s)
Communicable Diseases/epidemiology , Drug Resistance, Multiple, Bacterial/genetics , Mycobacterium tuberculosis/pathogenicity , Tuberculosis, Pulmonary/epidemiology , Base Sequence , Communicable Diseases/microbiology , DNA, Bacterial/genetics , Genome, Bacterial/genetics , Genotype , Humans , Macrophages/microbiology , Male , Middle Aged , Mycobacterium tuberculosis/classification , Mycobacterium tuberculosis/isolation & purification , Polymorphism, Single Nucleotide/genetics , Sequence Analysis, DNA , Spain/epidemiology , Tuberculosis, Pulmonary/microbiology , Virulence/genetics
4.
J. physiol. biochem ; 68(2): 175-179, jun. 2012.
Article in English | IBECS | ID: ibc-122337

ABSTRACT

This study sought to evaluate the effect of classical music, using Mozart’s sonata for two pianos (K. 448), on changes in dopamine (DA) levels in the striatal nucleus (SN), prefrontal cortex (PFC) and mesencephalon, and on prolactin (PRL) and corticosterone secretion in adult male Wistar rats. Rats were divided into four groups: (1) control, (2) haloperidol treatment (single dose of 2 mg/kg s.c.), (3) music (two 2-h sessions per day) and (4) haloperidol plus music. Rats were sacrificed 2 h after haloperidol injection. Music prompted a fall in plasma PRL and corticosterone levels in healthy rats (P < 0.05) and prevented the increase in levels triggered by haloperidol (P < 0.001). Moreover, exposure to music was associated with a significant increase in DA levels in all groups, with the increase being particularly marked in PFC and SN (P < 0.001). Haloperidol is a recognised D2 receptor antagonist, and these findings suggest that music, by contrast, enhances DA activity and turnover in the brain. The results obtained here bear out reports that music triggers a reduction in systolic pressure and an increase in mesencephalon dopamine levels in human and rats treated with ecstasy, through a calmodulin-dependent system (AU)


Subject(s)
Animals , Rats , Haloperidol/pharmacokinetics , Dopamine , Music Therapy/methods , Calmodulin/pharmacokinetics , Calcium-Calmodulin-Dependent Protein Kinases
5.
J Physiol Biochem ; 68(2): 175-9, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22371013

ABSTRACT

This study sought to evaluate the effect of classical music, using Mozart's sonata for two pianos (K. 448), on changes in dopamine (DA) levels in the striatal nucleus (SN), prefrontal cortex (PFC) and mesencephalon, and on prolactin (PRL) and corticosterone secretion in adult male Wistar rats. Rats were divided into four groups: (1) control, (2) haloperidol treatment (single dose of 2 mg/kg s.c.), (3) music (two 2-h sessions per day) and (4) haloperidol plus music. Rats were sacrificed 2 h after haloperidol injection. Music prompted a fall in plasma PRL and corticosterone levels in healthy rats (P < 0.05) and prevented the increase in levels triggered by haloperidol (P < 0.001). Moreover, exposure to music was associated with a significant increase in DA levels in all groups, with the increase being particularly marked in PFC and SN (P < 0.001). Haloperidol is a recognised D2 receptor antagonist, and these findings suggest that music, by contrast, enhances DA activity and turnover in the brain. The results obtained here bear out reports that music triggers a reduction in systolic pressure and an increase in mesencephalon dopamine levels in human and rats treated with ecstasy, through a calmodulin-dependent system.


Subject(s)
Acoustic Stimulation , Dopamine Antagonists/pharmacology , Haloperidol/pharmacology , Music , Animals , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Corticosterone/blood , Dopamine/metabolism , Male , Mesencephalon/drug effects , Mesencephalon/metabolism , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Prolactin/blood , Prolactin/metabolism , Rats , Rats, Wistar
6.
Pancreas ; 40(3): 410-4, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21178648

ABSTRACT

OBJECTIVE: The purpose of our study was to evaluate the effects of the addition of melatonin and capecitabine on experimental pancreatic cancer. METHODS: Fifty Syrian hamsters were randomized in 5 groups: group 1: no tumor induction (control group); group 2: tumor induction with BOP [N-nitrosobis(2-oxopropyl) amine]; group 3: tumor induction with BOP and melatonin administration; group 4: tumor induction with BOP and capecitabine administration; and group 5: tumor induction with BOP and administration of combined capecitabine and melatonin therapy. The evaluation of pathological tumor evolution and oxidative stress markers in pancreatic tissue was carried out. RESULTS: All animals under BOP exposure presented poorly or moderately differentiated pancreatic adenocarcinoma associated with increased lipoperoxide levels and decreased antioxidant activity in pancreatic tissue. Pancreatic cancer was shown in only 66% of the capecitabine-treated group and 33% of melatonin-treated group (P < 0.05), most of them moderately differentiated adenocarcinoma. When capecitabine and melatonin were combined, a well-differentiated pancreatic adenocarcinoma was observed in 10% of animals. The beneficial effect was associated with a decrease in lipoperoxide levels and increased antioxidant activity in pancreatic tissue. CONCLUSIONS: The combined administration of capecitabine and melatonin provided an improvement in antioxidant status as well as a synergistic antitumoral effect in experimental pancreatic cancer.


Subject(s)
Antimetabolites, Antineoplastic/administration & dosage , Deoxycytidine/analogs & derivatives , Fluorouracil/analogs & derivatives , Melatonin/administration & dosage , Pancreatic Neoplasms/drug therapy , Adenocarcinoma/chemically induced , Adenocarcinoma/drug therapy , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Animals , Antioxidants/administration & dosage , Antioxidants/metabolism , Capecitabine , Cricetinae , Deoxycytidine/administration & dosage , Drug Synergism , Drug Therapy, Combination , Fluorouracil/administration & dosage , Lipid Peroxides/metabolism , Male , Mesocricetus , Nitrosamines/toxicity , Pancreatic Neoplasms/chemically induced , Pancreatic Neoplasms/metabolism , Pancreatic Neoplasms/pathology , Prodrugs/administration & dosage
7.
J Pineal Res ; 49(3): 264-70, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20626589

ABSTRACT

Pancreatic cancer is a major health problem because of the aggressiveness of the disease and the lack of effective systemic therapies. Melatonin (MEL) has antioxidant activity and prevents experimental genotoxicity. The specific inhibitor of cyclooxygenase-2 (COX-2), celecoxib (CEL), increases the efficacy of chemoradiotherapy in advanced pancreatic cancer. The objective of the study was the comparison and synergic effect of MEL and CEL during either the induction or progression phases of the tumor process, measuring parameters of oxidative stress, number of tumor nodules and survival of animals with pancreatic cancer. Pancreatic cancer was induced by N-nitrosobis (2-oxopropyl)amine) (BOP) in Syrian hamsters. Melatonin and/or CEL were administered during the induction, postinduction as well as during both phases. The presence of tumor nodules were observed macroscopically in pancreatic and splenic areas, and the levels of lipoperoxides (LPO), reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) in pancreatic tissue were measured. The increases in tumor nodules and LPO as well as the reductions in GSH and enzymatic antioxidants in the pancreas induced by BOP were related to a lower survival rate of animals. The administration of MEL exerted a more potent beneficial effect than CEL treatment on the reduction in tumor nodules, oxidative stress and death of experimental BOP-treated animals. The combined treatment only exerted a synergistic beneficial effect when administered during the induction phase. Melatonin by itself had significant beneficial actions in improving the survival of hamsters.


Subject(s)
Antioxidants/therapeutic use , Cyclooxygenase 2 Inhibitors/therapeutic use , Melatonin/therapeutic use , Pancreatic Neoplasms/drug therapy , Pancreatic Neoplasms/metabolism , Pyrazoles/therapeutic use , Sulfonamides/therapeutic use , Animals , Antioxidants/pharmacology , Catalase/metabolism , Celecoxib , Cricetinae , Cyclooxygenase 2 Inhibitors/pharmacology , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Lipid Peroxides/metabolism , Melatonin/pharmacology , Mesocricetus , Oxidative Stress/drug effects , Pyrazoles/pharmacology , Sulfonamides/pharmacology , Superoxide Dismutase/metabolism
8.
Neurochem Res ; 35(8): 1182-7, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20428940

ABSTRACT

We studied the effects of transcranial magnetic stimulation (TMS, 60 Hz and 0.7 mT for 4 h/day for 14 days) on oxidative and cell damage caused by olfactory bulbectomy (OBX) in Wistar rats. The levels of lipid peroxidation products and caspase-3 were enhanced by OBX, whereas it prompted a reduction in reduced glutathione (GSH) content and antioxidative enzymes activities. The treatment with TMS reverted towards normality the biomarkers indicative of oxidative stress and apoptosis. In conclusion, our data show that TMS induced a protection against cell and oxidative damage induced by OBX, as well as they support the hypothesis that oxidative stress may play an important role in depression.


Subject(s)
Antioxidants/metabolism , Depression/therapy , Olfactory Bulb , Oxidative Stress , Transcranial Magnetic Stimulation , Animals , Biomarkers/metabolism , Brain/metabolism , Caspase 3/metabolism , Depression/etiology , Depression/metabolism , Glutathione/metabolism , L-Lactate Dehydrogenase/metabolism , Lipid Peroxidation , Male , Rats , Rats, Wistar , Superoxide Dismutase/metabolism
9.
Eur J Pharmacol ; 627(1-3): 115-8, 2010 Feb 10.
Article in English | MEDLINE | ID: mdl-19887066

ABSTRACT

We evaluated the effects of nicotine on cell and oxidative damage caused by olfactory bulbectomy (OBX). The rats were divided into seven groups as follows: i) control; ii) vehicle (6% ethanol); iii) treated with nicotine; iv) sham operated; v) olfactory bulbectomy (OBX); vi) OBX+vehicle; and vii) OBX+Nic. The OBX was performed using the trepanation of frontal bone. The olfactory bulbs were cut and removed without damage to the frontal cortex. Two weeks after surgery nicotine was administered chronically once daily for 14 days, intraperitoneally (i.p.) in doses of 1.5 mg/kg, two weeks after surgery. OBX caused an increase in lipid peroxidation products and caspase-3 but prompted a reduction in reduced glutathione (GSH) content and antioxidative enzyme activity. All these changes were reverted by treatment of nicotine (14 days). In conclusions: i) OBX induces oxidative stress and cell death by apoptosis; and ii) nicotine presents antidepressant and antioxidant effect. All these findings suggest that nicotine would be a therapeutic tool for depression, although more studies are needed in this area to define the appropriate treatment regime.


Subject(s)
Antioxidants/pharmacology , Depressive Disorder/metabolism , Depressive Disorder/pathology , Nicotine/pharmacology , Olfactory Bulb/surgery , Oxidative Stress/drug effects , Animals , Antioxidants/therapeutic use , Anxiety/drug therapy , Behavior, Animal/drug effects , Biomarkers/metabolism , Depressive Disorder/drug therapy , Depressive Disorder/etiology , Male , Nicotine/therapeutic use , Rats , Rats, Sprague-Dawley
10.
Pharmacology ; 83(4): 211-6, 2009.
Article in English | MEDLINE | ID: mdl-19204412

ABSTRACT

UNLABELLED: The present study evaluated the effect of infliximab on the myeloperoxidase (MPO) concentration in chronic inflammatory joint disease. Eighteen patients were divided into active and inactive groups. Erythrocyte sedimentation rate, C-reactive protein, white blood cell counts, MPO concentration, and biomarkers of oxidative stress were measured before and after the infusion of infliximab. Patients with active disease showed increases in concentrations of MPO and biomarkers of oxidation, but decreases in antioxidant parameters. After infliximab treatment, both inflammatory parameters and MPO concentrations were normalized. IN CONCLUSION: (1) the MPO concentration is related to inflammatory activity and could play an important role in the maintenance and outbreak of oxidative stress present in these diseases, and (2) infliximab inhibits MPO concentration.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antibodies, Monoclonal/pharmacology , Arthritis, Rheumatoid/enzymology , Peroxidase/blood , Spondylitis, Ankylosing/enzymology , Adult , Aged , Anti-Inflammatory Agents/therapeutic use , Antibodies, Monoclonal/therapeutic use , Arthritis, Rheumatoid/drug therapy , Biomarkers/blood , Female , Humans , Infliximab , Male , Middle Aged , Oxidative Stress/drug effects , Peroxidase/adverse effects , Spondylitis, Ankylosing/drug therapy
12.
Neuropsychiatr Dis Treat ; 4(2): 441-9, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18728794

ABSTRACT

The present study evaluated 17beta-estradiol (17betaE(2)) (2.5 mg/kg sc) effects on bilateral OBX-induced behavioral changes and oxidative stress. OBX in male Wistar rats produced an increase in lipid peroxidation products and a decline in reduced glutathione (GSH) content and glutathione peroxidase (GSH-Px) activity, together with an increase in caspase-3 activity. Additionally, OBX triggered changes of behavior such as an enhancement of immobility time in the forced swim test and hyperactivity in the open field test. These changes were reversed by treatment with 17betaE(2) (14 days). Our results reveled that 17betaE(2) has a protective effect against oxidative stress, cell damage and behavioral changes induced by OBX, and present antidepressant and antianxiety properties.

13.
Chem Biol Interact ; 174(2): 79-87, 2008 Jul 30.
Article in English | MEDLINE | ID: mdl-18571630

ABSTRACT

Melatonin and S-adenosyl-l-methionine (SAMe) prevent oxidative stress and tissue dysfunction in obstructive jaundice (OJ). Lipid peroxidation is exacerbated in the presence of trace amounts of iron (Fe). The study investigated the regulation by melatonin and SAMe the induction of oxidative stress, iron metabolism disturbances and tissue injury in an experimental model of OJ. Different parameters of lipid peroxidation, antioxidant status, tissue injury and Fe metabolism were determined in liver and blood. OJ induced Fe accumulation in liver, and increased transferrin (Tf) saturation and loosely bound Fe content in blood. Melatonin, and SAMe at lesser extent, enhanced protein Tf content in liver and blood, that reduced loosely bound Fe content in blood. Melatonin and SAMe did not affect ferritin (FT) and Tf mRNA expression, but reduced Tf receptor (TfR) mRNA expression in liver. In conclusion, the effect of melatonin and SAMe on Fe metabolism may be included in the beneficial properties of these agents on lipid peroxidation and tissue injury induced by OJ.


Subject(s)
Antioxidants/pharmacology , Jaundice, Obstructive/drug therapy , Liver/drug effects , Melatonin/pharmacology , Oxidative Stress/drug effects , S-Adenosylmethionine/pharmacology , Transferrin/metabolism , Animals , Antioxidants/metabolism , Apoptosis/drug effects , Disease Models, Animal , Ferritins/genetics , Gene Expression/drug effects , Jaundice, Obstructive/metabolism , Jaundice, Obstructive/pathology , Lipid Peroxidation/drug effects , Liver/metabolism , Liver/pathology , Male , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptors, Transferrin/genetics , Transferrin/genetics
14.
J Pineal Res ; 43(3): 270-5, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17803524

ABSTRACT

Pancreatic cancer is a major health problem because of the aggressiveness of the disease and the lack of effective systemic therapies. Melatonin has antioxidant activity and prevents experimental genotoxicity. However, the effect of melatonin in pancreatic cancer has not been tested. Pancreatic carcinogenesis was induced by N-nitrosobis (2-oxopropyl)amine (BOP) in Syrian hamsters. Melatonin was administered during the BOP-induction phase (12 wk) and/or following the postinduction phase (12 wk). Different parameters of oxidative stress including lipid peroxides (LPO) and antioxidants (superoxide dismutase, catalase, reduced glutathione and glutathione peroxidase) were determined in pancreatic tissue. Also, the presence of atypical hyperplasia (AH), well and moderately differentiated adenomacarcinoma (ADC-WD and ADC-MD, respectively) were studied. The administration of BOP induced an intense oxidative stress and ADC induction in the pancreas. The administration of melatonin during the induction or postinduction phase reduced LPO and improved the antioxidant status, as well as drastically reducing the presence of ADC but some AH remained. In conclusion, treatment with melatonin reduced oxidative damage and cancer nodules induced by BOP in the pancreas.


Subject(s)
Melatonin/therapeutic use , Pancreatic Neoplasms/drug therapy , Pancreatic Neoplasms/pathology , Animals , Antioxidants/metabolism , Body Weight/drug effects , Cricetinae , Disease Models, Animal , Lipid Peroxides/metabolism , Male , Nitrosamines/pharmacology , Pancreatic Neoplasms/chemically induced , Pancreatic Neoplasms/metabolism
15.
J Neurosci Res ; 85(16): 3652-6, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17671989

ABSTRACT

The aim of the study was to analyze the impact of melatonin on brain oxidative stress in experimental biliary obstruction. Cholestasis was done by a double ligature and section of the extrahepatic biliary duct. Melatonin was injected intraperitoneally (500 microg/kg/day). Malondialdehyde (MDA), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) contents were determined in the brain tissue. Biliary obstruction raised MDA and reduced GSH contents in the cortex, cerebellum, and hypothalamus areas. Moreover, the scavenger enzyme activity significantly dropped in all areas of the brain. Melatonin drastically reduced MDA concentration and enhanced GSH concentration, as well as all antioxidant enzyme activity in all brain areas obtained from the bile duct-ligated animals. In conclusion, the treatment with melatonin decreased lipid peroxidation and recovered the antioxidant status in the brain from cholestatic animals.


Subject(s)
Brain/drug effects , Hepatic Encephalopathy/drug therapy , Jaundice, Obstructive/complications , Melatonin/pharmacology , Oxidative Stress/physiology , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Bile Ducts, Extrahepatic/injuries , Bile Ducts, Extrahepatic/physiopathology , Brain/metabolism , Brain/physiopathology , Catalase/metabolism , Disease Models, Animal , Free Radical Scavengers/metabolism , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Hepatic Encephalopathy/metabolism , Hepatic Encephalopathy/physiopathology , Lipid Peroxidation/drug effects , Lipid Peroxidation/physiology , Male , Malondialdehyde/metabolism , Melatonin/therapeutic use , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Oxidative Stress/drug effects , Rats , Rats, Wistar , Superoxide Dismutase/metabolism
16.
Life Sci ; 80(13): 1221-7, 2007 Mar 06.
Article in English | MEDLINE | ID: mdl-17266993

ABSTRACT

This paper evaluates the effects of testosterone (0.5 mg/kg subcutaneously (s.c.) for 8 days) on oxidative stress and cell damage induced by 3-nitropropionic acid (20 mg/kg intraperitoneally (i.p.) for 4 days) in ovariectomized rats. Gonadectomy triggered oxidative damage and cell loss, evaluated by the detection of caspase-3, whereas 3-nitropropionic acid increased the levels of oxidative stress induced by ovariectomy and prompted cell damage characterized by enhanced levels of lactate dehydrogenase. These changes were blocked by testosterone administration. Our results support the following conclusions: i) ovariectomy triggers oxidative and cell damage via caspase-3 in the striatum; ii) 3-nitropropionic acid exacerbates oxidative stress induced by ovariectomy and leads to cell damage characterized by increased levels of lactate dehydrogenase; iii) testosterone administration decreases oxidative stress and cell damage. Additionally, these data support the hypothesis that testosterone might play an important role in the onset and development of neurodegenerative diseases.


Subject(s)
Androgens/pharmacology , Corpus Striatum/drug effects , Neurotoxins/toxicity , Nitro Compounds/toxicity , Oxidative Stress/drug effects , Propionates/toxicity , Testosterone/pharmacology , Animals , Cell Death/drug effects , Corpus Striatum/metabolism , Corpus Striatum/pathology , Disease Models, Animal , Drug Antagonism , Female , Huntington Disease , Injections, Intraperitoneal , Injections, Subcutaneous , L-Lactate Dehydrogenase/metabolism , Lipid Peroxidation/drug effects , Ovariectomy , Rats , Rats, Wistar
17.
Cell Biochem Funct ; 25(2): 119-27, 2007.
Article in English | MEDLINE | ID: mdl-16245358

ABSTRACT

This study was designed to evaluate and compare the effect of melatonin, vitamin E and L-carnitine on brain and liver oxidative stress and liver damage. Oxidative stress and hepatic failure were produced by a single dose of thioacetamide (TAA) (150 mg kg(-1)) in Wistar rats. A dose of either melatonin (3 mg kg(-1)) vitamin E (20 mg kg(-1) ) or L-carnitine (100 mg kg(-1)) was used. Blood samples were taken from the neck vasculature in order to determine ammonium, blood urea nitrogen (BUN) and liver enzymes. Lipid peroxidation products, glutathione (GSH) content and antioxidative enzymes were determined in cerebral and hepatic homogenates. The results showed a decrease in BUN and in the antioxidant enzymes activities and GSH in the brain and liver. Likewise, TAA induced significant enhancement of lipid peroxidation products levels in both liver and brain, as well as in ammonia values. Melatonin, vitamin E and L-carnitine, although melatonin more significantly, decreased the intensity of the changes produced by the administration of TAA alone. Furthermore melatonin combined with TAA, decreased the ammonia levels and increased the BUN values compared with TAA animals. Also it was more effective than vitamin E or L-carnitine in these actions. These data show the protective effect of these agents, especially melatonin, against oxidative stress and hepatic damage present in fulminant hepatic failure.


Subject(s)
Brain/metabolism , Carnitine/therapeutic use , Liver Failure/prevention & control , Melatonin/therapeutic use , Protective Agents/therapeutic use , Vitamin E/therapeutic use , Ammonia/blood , Animals , Blood Urea Nitrogen , Glutathione/blood , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/enzymology , Liver Failure/chemically induced , Liver Failure/metabolism , Male , Oxidative Stress/drug effects , Rats , Rats, Wistar , Thioacetamide
18.
Neurosci Res ; 56(1): 91-5, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16837092

ABSTRACT

This study evaluates the effect of transcranial magnetic stimulation (TMS; 60 Hz and 0.7 mT) treatment on 3-nitropropionic acid (20 mg/kg i.p./day for 4 days)-induced oxidative stress in cortical synaptosomes of Wistar rats. The oxidative derangement was confirmed by a high level of lipid peroxidation products and protein carbonyls, together with a decreased in reduced glutathione (GSH) content, catalase and GSH-peroxidase (GSH-Px) activities. Additionally, it was observed a reduction in succinate dehydrogenase (SDH) activity. All changes were partially prevented or reversed by administration of TMS. These results show that TMS reduces oxidative stress in cortical synaptosomes, and suggest that TMS may protect neuronal and maintain synaptic integrity.


Subject(s)
Cerebral Cortex/cytology , Nitro Compounds/pharmacology , Oxidative Stress , Propionates/pharmacology , Synaptosomes/drug effects , Transcranial Magnetic Stimulation , Animals , Biomarkers/metabolism , Cerebral Cortex/drug effects , Convulsants/pharmacology , Male , Rats , Rats, Wistar , Succinate Dehydrogenase/metabolism
19.
Pharmacol Res ; 54(3): 241-6, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16829126

ABSTRACT

The effect of carvedilol on oxidative and cell damage induced by okadaic acid in N1E-115 cells were studied. The effects of okadaic acid were evaluated as changes in: the quantity of lipid peroxidation products, protein carbonyl groups, reduced glutathione content (GSH), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), catalase and total lactate dehydrogenase (cell LDH). Additionally, a dose of carvedilol (10(-5)M) was added 2h before incubation with okadaic acid (50 nM) and was present until the end of the experiment (2h later added okadaic acid). Our results reveal that okadaic acid induces oxidative stress and an increase of cell LDH in N1E-115 cells, whereas carvedilol prevented the changes prompted by okadaic acid. In conclusion, the data show the protective effect of carvedilol, as well as its ability to modify cell response to okadaic acid, involving like cytoprotective mechanism its antioxidative properties.


Subject(s)
Carbazoles/pharmacology , Okadaic Acid/toxicity , Propanolamines/pharmacology , Animals , Carvedilol , Catalase/metabolism , Cell Line, Tumor , Drug Interactions , Glutathione/metabolism , Glutathione Peroxidase/metabolism , L-Lactate Dehydrogenase/metabolism , Lipid Peroxidation/drug effects , Melatonin/metabolism , Mice , Neuroblastoma , Oxidation-Reduction , Oxidative Stress/drug effects , Proteins/metabolism , Superoxide Dismutase/metabolism
20.
Acta Neurobiol Exp (Wars) ; 66(1): 1-6, 2006.
Article in English | MEDLINE | ID: mdl-16617671

ABSTRACT

Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter synthesized by the aromatic amino acid decarboxylase using 5-hydroxytryptophan (5-HTP) as a substrate. It was recently shown that serotonin and its precursor have powerful antioxidant properties. The aim of this study was to evaluate the effect of reduction in 5-HT levels by parachlorophenylalanine (pCPA) and their restoration by 5-HTP administration on lipid peroxidation and antioxidant status in rat brain. Serotonin levels were decreased by p-chlorophenylalanine administration. The effect of p-chlorophenylalanine was counteracted by the intraperitoneal administration of 5-hydroxytryptophan. We evaluated the concentration of serotonin, malonyl dialdehyde and the status of antioxidants (GSH, catalase and superoxide dismutase) in brain. The results showed that p-chlorophenylalanine (300 mg/kg) induced a depletion of serotonin concentration and antioxidant status, as well as enhancing malonyl dialdehyde concentration in brain. The exogenous administration of 5-hydroxytryptophan prevented all effects induced by p-chlorophenylalanine in brain tissue. The recovery of the neurotransmitter concentration in brain was related to the reduction of lipid peroxide generation and improved antioxidant status. In conclusion, our study supports the view that the antioxidant properties of serotonin protect against basal oxidative stress in brain.


Subject(s)
Cerebral Cortex/physiology , Oxidative Stress/physiology , Serotonin/physiology , 5-Hydroxytryptophan/pharmacology , Analysis of Variance , Animals , Catalase/metabolism , Cerebral Cortex/drug effects , Dose-Response Relationship, Drug , Drug Interactions , Fenclonine/pharmacology , Glutathione/metabolism , Lipid Peroxides/metabolism , Male , Oxidative Stress/drug effects , Rats , Rats, Wistar , Serotonin Antagonists/pharmacology , Superoxide Dismutase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...